BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32165026)

  • 1. Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss!
    Lopez MI; Grant RM; Dong BJ
    J Am Pharm Assoc (2003); 2020; 60(4):e18-e24. PubMed ID: 32165026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes about community pharmacy access to HIV prevention medications in California.
    Koester KA; Saberi P; Fuller SM; Arnold EA; Steward WT
    J Am Pharm Assoc (2003); 2020; 60(6):e179-e183. PubMed ID: 32665097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health.
    Lopez MI; Cocohoba J; Cohen SE; Trainor N; Levy MM; Dong BJ
    J Am Pharm Assoc (2003); 2020; 60(1):138-144. PubMed ID: 31405804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists.
    Hopkins R; Josma D; Morris J; Klepser DG; Young HN; Crawford ND
    J Am Pharm Assoc (2003); 2021; 61(1):115-120. PubMed ID: 33214059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California.
    Hunter LA; Packel LJ; Chitle P; Beltran RM; Rafie S; De Martini L; Dong B; Harris O; Holloway IW; Miyashita Ochoa A; McCoy SI
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad549. PubMed ID: 38023549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Community Pharmacies in Providing Access to HIV Post-exposure Prophylaxis (PEP).
    Scarnati K; Esser K; Sahloff EG; Duggan J
    J Community Health; 2024 Apr; 49(2):222-228. PubMed ID: 37759138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.
    Zhao A; Dangerfield DT; Nunn A; Patel R; Farley JE; Ugoji CC; Dean LT
    AIDS Behav; 2022 May; 26(5):1377-1392. PubMed ID: 34669062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men.
    Crawford ND; Josma D; Morris J; Hopkins R; Young HN
    J Am Pharm Assoc (2003); 2020; 60(4):602-608. PubMed ID: 32007364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitators and barriers to community pharmacy PrEP delivery: a scoping review.
    Harrison C; Family H; Kesten J; Denford S; Scott A; Dawson S; Scott J; Sabin C; Copping J; Harryman L; Cochrane S; Horwood J
    J Int AIDS Soc; 2024 Mar; 27(3):e26232. PubMed ID: 38494652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
    Shaeer KM; Sherman EM; Shafiq S; Hardigan P
    J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US.
    Harrington KRV; Chandra C; Alohan DI; Cruz D; Young HN; Siegler AJ; Crawford ND
    JAMA Netw Open; 2023 Jul; 6(7):e2326028. PubMed ID: 37498599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies.
    Bellman R; Mohebbi S; Nobahar N; Parizher J; Apollonio DE
    J Am Pharm Assoc (2003); 2022; 62(1):370-377.e3. PubMed ID: 34429253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.
    Farmer EK; Koren DE; Cha A; Grossman K; Cates DW
    AIDS Patient Care STDS; 2019 May; 33(5):207-213. PubMed ID: 31067124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy.
    Lutz S; Heberling M; Goodlet KJ
    J Am Pharm Assoc (2003); 2021; 61(2):e75-e79. PubMed ID: 33069595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state.
    Unni EJ; Lian N; Kuykendall W
    J Am Pharm Assoc (2003); 2016; 56(5):527-532.e1. PubMed ID: 27594106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-exposure and post-exposure prophylaxis access in rural versus urban pharmacies in Georgia and Pennsylvania.
    Kislovskiy Y; Pino N; Crawford ND; Woitas T; Cason S; Konka A; Kimble T; Olson I; Villarreal D; Jarlenski M
    J Am Pharm Assoc (2003); 2024 Apr; ():102084. PubMed ID: 38574992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health.
    Okoro O; Hillman L
    J Am Pharm Assoc (2003); 2018; 58(4):412-420.e3. PubMed ID: 29789257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation.
    Ortblad KF; Mogere P; Roche S; Kamolloh K; Odoyo J; Irungu E; Mugo NR; Pintye J; Baeten JM; Bukusi E; Ngure K;
    BMC Health Serv Res; 2020 Nov; 20(1):1034. PubMed ID: 33176785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the performance of HIV self-testing at private pharmacies in Kenya: a cross-sectional study.
    Ortblad KF; Kwach B; Zhang S; Asewe M; Ongwen PA; Malen RC; Harkey K; Odoyo J; Gathii P; Rota G; Sharma M; Were DK; Ngure K; Omollo V; Bukusi EA
    J Int AIDS Soc; 2023 Oct; 26(10):e26177. PubMed ID: 37848405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating and Disseminating Pre-Exposure Prophylaxis (PrEP) Screening and Dispensing for Black Men Who Have Sex With Men in Atlanta, Georgia: Protocol for Community Pharmacies.
    Crawford ND; Harrington KRV; Alohan DI; Sullivan PS; Holland DP; Klepser DG; Quamina A; Siegler AJ; Young HN
    JMIR Res Protoc; 2022 Feb; 11(2):e35590. PubMed ID: 35138252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.